4AX0
Q157A mutant. Crystal Structure of the Mobile Metallo-beta-Lactamase AIM-1 from Pseudomonas aeruginosa: Insights into Antibiotic Binding and the role of Gln157
4AX0 の概要
| エントリーDOI | 10.2210/pdb4ax0/pdb |
| 関連するPDBエントリー | 4AWY 4AWZ 4AX1 |
| 分子名称 | METALLO-BETA-LACTAMASE AIM-1, ZINC ION, CALCIUM ION, ... (5 entities in total) |
| 機能のキーワード | hydrolase, antibiotic resistance, acquired b3, drug binding site |
| 由来する生物種 | PSEUDOMONAS AERUGINOSA |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 32132.89 |
| 構造登録者 | Leiros, H.-K.S.,Borra, P.S.,Brandsdal, B.O.,Edvardsen, K.S.W.,Spencer, J.,Walsh, T.R.,Samuelsen, O. (登録日: 2012-06-06, 公開日: 2012-06-20, 最終更新日: 2024-10-23) |
| 主引用文献 | Leiros, H.-K.S.,Borra, P.S.,Brandsdal, B.O.,Edvardsen, K.S.W.,Spencer, J.,Walsh, T.R.,Samuelsen, O. Crystal Structure of the Mobile Metallo-Beta-Lactamase Aim-1 from Pseudomonas Aeruginosa: Insights Into Antibiotic Binding and the Role of Gln157 Antimicrob.Agents Chemother., 56:4341-, 2012 Cited by PubMed Abstract: Metallo-β-lactamase (MBL) genes confer resistance to virtually all β-lactam antibiotics and are rapidly disseminated by mobile genetic elements in Gram-negative bacteria. MBLs belong to three different subgroups, B1, B2, and B3, with the mobile MBLs largely confined to subgroup B1. The B3 MBLs are a divergent subgroup of predominantly chromosomally encoded enzymes. AIM-1 (Adelaide IMipenmase 1) from Pseudomonas aeruginosa was the first B3 MBL to be identified on a readily mobile genetic element. Here we present the crystal structure of AIM-1 and use in silico docking and quantum mechanics and molecular mechanics (QM/MM) calculations, together with site-directed mutagenesis, to investigate its interaction with β-lactams. AIM-1 adopts the characteristic αβ/βα sandwich fold of MBLs but differs from other B3 enzymes in the conformation of an active site loop (residues 156 to 162) which is involved both in disulfide bond formation and, we suggest, interaction with substrates. The structure, together with docking and QM/MM calculations, indicates that the AIM-1 substrate binding site is narrower and more restricted than those of other B3 MBLs, possibly explaining its higher catalytic efficiency. The location of Gln157 adjacent to the AIM-1 zinc center suggests a role in drug binding that is supported by our in silico studies. However, replacement of this residue by either Asn or Ala resulted in only modest reductions in AIM-1 activity against the majority of β-lactam substrates, indicating that this function is nonessential. Our study reveals AIM-1 to be a subclass B3 MBL with novel structural and mechanistic features. PubMed: 22664968DOI: 10.1128/AAC.00448-12 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.74 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






